AAAAAA

   
Results: 1-3 |
Results: 3
An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity (vol19, pg 3968, 2001)
Authors: Linglof, T van Hattum, J Kaplan, KM Corrigan, J Duval, I Jensen, E Kuter, B
Citation: T. Linglof et al., An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity (vol19, pg 3968, 2001), VACCINE, 20(1-2), 2001, pp. 281-281
An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity
Authors: Linglof, T van Hattum, J Kaplan, KM Corrigan, J Duval, I Jensen, E Kuter, B
Citation: T. Linglof et al., An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity, VACCINE, 19(28-29), 2001, pp. 3968-3971
Piperacillin/tazobactam versus cefotaxime plus metronidazole for the treatment of severe intra-abdominal infection in hospitalized pediatric patients
Authors: Adam, D Linglof, T Floret, D Kirsch, T
Citation: D. Adam et al., Piperacillin/tazobactam versus cefotaxime plus metronidazole for the treatment of severe intra-abdominal infection in hospitalized pediatric patients, CURR THER R, 62(6), 2001, pp. 488-502
Risultati: 1-3 |